Company Info
Year Established2018
Contacts
Noam Solomon, PhDCo-Founder & CEO
Evan Zisholtz
VP, Corporate Development
Tali Raveh-Sadka, PhD
VP, Computational R&D
Gail Katz, JD
VP, IP
Sen Zhang
VP, Product
Roy Cohen
VP, Finance
Elisha Nathan
VP, Strategic Alliances
Company Description
Immunai was founded on the belief that immunomics and machine learning could unlock the next generation of immunomodulatory drugs.
